Wei Sang
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 1%
- Nanoplatforms for cancer theranostics
Papers in ⓘ
- Oncology 46
- CAR-T cell therapy research 19
- Viral-associated cancers and disorders 13
- Co-authors
- Yunlu Dai (25 shared papers)Zhan Zhang (22 shared papers)Jie Li (17 shared papers)Lisi Xie (16 shared papers)Bei Li (15 shared papers)Jie Yan (11 shared papers)Wenxi Li (15 shared papers)Hao Tian (15 shared papers)
- Journals
- Frontiers in Immunology (8 papers)Journal of Nuclear Materials (5 papers)Nano Research (4 papers)Frontiers in Oncology (4 papers)Advanced Science (4 papers)
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Wei Sang
181 papers receiving 5.4k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Biomaterials 643
- Biomedical Engineering 2.0k
- Renewable Energy, Sustainability and the Environment 694
- Immunology 825
- Biochemistry 200
Countries citing papers authored by Wei Sang
This map shows the geographic impact of Wei Sang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Sang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Sang more than expected).
Fields of papers citing papers by Wei Sang
This network shows the impact of papers produced by Wei Sang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Sang. The network helps show where Wei Sang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Sang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 195 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Recent advances in nanomaterial-based synergistic combination cancer immunotherapy Hit paper breakdown → | 2019 | 343 |
| 2 | 2015 | 319 | |
| 3 | Phototheranostic Metal-Phenolic Networks with Antiexosomal PD-L1 Enhanced Ferroptosis for Synergistic Immunotherapy Hit paper breakdown → | 2022 | 251 |
| 4 | 2017 | 217 | |
| 5 | Engineering Radiosensitizer‐Based Metal‐Phenolic Networks Potentiate STING Pathway Activation for Advanced Radiotherapy Hit paper breakdown → | 2021 | 206 |
| 6 | 2009 | 194 | |
| 7 | A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis Hit paper breakdown → | 2021 | 169 |
| 8 | 2021 | 146 | |
| 9 | 2009 | 145 | |
| 10 | 2021 | 140 | |
| 11 | 2020 | 137 | |
| 12 | 2022 | 135 | |
| 13 | 2020 | 131 | |
| 14 | 2019 | 127 | |
| 15 | 2018 | 126 | |
| 16 | 2015 | 122 | |
| 17 | 2020 | 115 | |
| 18 | 2022 | 89 | |
| 19 | 2019 | 66 | |
| 20 | 2015 | 61 |
About Wei Sang
Wei Sang is a scholar working on Molecular Biology, Oncology, Biomedical Engineering, Immunology and Pathology and Forensic Medicine, having authored 195 papers that have together received 5.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (28 papers), Nanoplatforms for cancer theranostics (24 papers), CAR-T cell therapy research (19 papers), Immune Cell Function and Interaction (15 papers), Viral-associated cancers and disorders (13 papers), Asymmetric Hydrogenation and Catalysis (11 papers), Wheat and Barley Genetics and Pathology (10 papers) and Immunotherapy and Immune Responses (10 papers). The work is most often cited by research in Biomaterials (643 citations), Biomedical Engineering (2.0k citations), Renewable Energy, Sustainability and the Environment (694 citations), Immunology (825 citations) and Biochemistry (200 citations). Wei Sang has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Yunlu Dai, Zhan Zhang, Jie Li, Lisi Xie, Bei Li, Jie Yan, Wenxi Li, Hao Tian, Qiang Yan and Guixing Ren. Their work appears in journals such as Frontiers in Immunology, Journal of Nuclear Materials, Nano Research, Frontiers in Oncology and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.